Serum Institute of India Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Serum Institute of India Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Serum Institute of India Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Serum Institute of India Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
38 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Serum Institute of India Limited (SIIL) is a pharmaceutical company that manufactures and produces vaccines and biologicals. The company offers polio vaccine, diphtheria, tetanus, pertussis, hib, BCG, r-hepatitis B, measles, mumps and rubella vaccines. It operates through three product segments such as manufactured products, marketed products and exported products. SIILs manufactured products include bacterial vaccines, viral vaccines, recombinant and combination vaccines, meningococcal A conjugate vaccine, anti cancer products and anti sera, plasma and hormonal products. The company offers marketed products such as hormonal products and other pharma products.

Serum Institute of India Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDPH141820D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Serum Institute of India Limited, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Serum Institute of India Limited, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Serum Institute of India Limited, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Serum Institute of India Limited, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Serum Institute of India Limited, Medical Devices Deals, 2010 to YTD 201691
Serum Institute of India Limited, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Serum Institute of India Limited, Pharmaceuticals &Healthcare, Deal Details1222
  Asset Purchase121
    Serum Institute of India Acquires Production Facilities Of Netherlands Vaccine Institute For US$40 Million121
  Private Equity131
    Serum Institute Plans to Sell Minority Stake in Itself131
  Partnerships141
    Cipla Enters into Distribution Agreement with Serum Institute141
    Cipla Enters into Distribution Agreement with Serum Institute of India151
    Merck Enters Into Co-Development Agreement With Serum Institute of India162
    VaxyGen Vaccines Enters Into Collaboration With Serum Institute Of India181
  Licensing Agreements191
    Serum Institute of India Enters into Licensing Agreement with Visterra192
    Genticel Enters into Licensing Agreement with Serum Institute of India211
    Serum Institute of India Enters into Licensing Agreement with NeuClone221
    Serum Institute of India Enters Into Licensing Agreement With Vakzine Projekt Management For VPM1002231
    Nanolek Enters into Licensing Agreement with Bilthoven Biologicals for IPV Vaccine241
    Lipoxen Terminates Licensing Agreement With Serum Institute of India251
    BioDiem Enters Into Licensing Agreement With Serum Institute Of India261
  Equity Offering271
    Akorn Completes Private Placement Of US$2.5 Million272
  Acquisition291
    Serum Institute Of India Acquires Bilthoven Biologicals, Monoclonal Antibodies And Vaccine Maker, For US$101 Million292
    Serum Institute Plans To Sell Its Stake In Akorn312
    Chongqing Zhifei Terminates Acquisition Of Bilthoven Biologicals331
Serum Institute of India Limited - Key Competitors341
Key Employees351
Locations And Subsidiaries362
  Head Office361
  Other Locations &Subsidiaries362
Appendix381
  Methodology381
  About GlobalData381
  Contact Us381
  Disclaimer381

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Serum Institute of India Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Serum-Institute-of-India-Limited-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-3030>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Serum Institute of India Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Serum-Institute-of-India-Limited-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-3030>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research